The nasal vestibule is a primary reservoir for potential bacterial pathogens, including multidrug-resistant organisms (MDROs), and colonization is associated with an increased risk of healthcare-associated infections (HAIs). Most patients meet at least one criterion that puts them at risk for nasal carriage and potential HAI, so targeting only “high-risk” patients may inadvertently overlook vulnerable individuals.
Universal nasal decolonization (UND) — treating all patients without prior screening — has been shown to reduce HAIs. With a broad-spectrum nasal antiseptic, UND can be an effective source control strategy: it reduces infections due to endogenous organisms in colonized patients, decreases transmission between patients, lowers MDRO acquisition and supports antimicrobial stewardship.
Download the white paper for:
- Why a universal approach protects patients that targeted strategies may miss.
- Evidence for universal decolonization across ICU, surgical, dialysis, burn and trauma, nursing home and pediatric settings.
- HAI cost-per-event data, length-of-stay impact, and published cost savings.
- How standardized care and simpler workflows improve efficiency and how an antiseptic-based approach supports antimicrobial stewardship.
